PROK
NASDAQ · Biotechnology
Prokidney Corp
$1.83
+0.04 (+2.23%)
Open$1.85
Previous Close$1.79
Day High$1.90
Day Low$1.80
52W High$7.13
52W Low$0.46
Volume—
Avg Volume629.4K
Market Cap586.58M
P/E Ratio—
EPS$-0.54
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+983.1% upside
Current
$1.83
$1.83
Target
$19.82
$19.82
$13.43
$19.82 avg
$25.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 233.5K | 45.98M | 42.93M |
| Net Income | -182,363,867 | 9.61M | 10.78M |
| Profit Margin | -80,507.9% | 20.9% | 25.1% |
| EBITDA | -531,245,294 | 17.18M | 13.92M |
| Free Cash Flow | — | 13.69M | 9.06M |
| Rev Growth | — | +20.4% | +3.7% |
| Debt/Equity | 0.00 | 0.62 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |